Clinical trial
Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With…
NCT00005946 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00005946 |
|---|---|
| Title | Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation |
| Official title | A Pilot Study of Combined Chemotherapy and Donor Lymphocyte Infusion for Hematologic Malignancies in Relapse After Allogeneic Bone Marrow Transplantation |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, therapeutic allogeneic lymphocytes, cyclophosphamide, etoposide |
| Start date | Oct 1, 2000 |
| Primary completion | Jun 1, 2002 |
| Completion | Jun 1, 2002 |
| First posted | Mar 5, 2004 |
| Last update posted | Oct 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: